BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Brown TT, Zelnik DL, Dobs AS. Fish oil supplementation in the treatment of cachexia in pancreatic cancer patients. Int J Gastrointest Cancer. 2003;34:143-150. [PMID: 15361649 DOI: 10.1385/ijgc:] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
Number Citing Articles
1 Oza VM, Kahaleh M. Endoscopic management of chronic pancreatitis. World J Gastrointest Endosc 2013; 5(1): 19-28 [PMID: 23330050 DOI: 10.4253/wjge.v5.i1.19] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
2 Altwegg R, Ychou M, Guillaumon V, Thezenas S, Senesse P, Flori N, Mazard T, Caillo L, Faure S, Samalin E, Assenat E. Second-line therapy for gemcitabine-pretreated advanced or metastatic pancreatic cancer. World J Gastroenterol 2012; 18(12): 1357-1364 [PMID: 22493549 DOI: 10.3748/wjg.v18.i12.1357] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
3 Mueller TC, Burmeister MA, Bachmann J, Martignoni ME. Cachexia and pancreatic cancer: Are there treatment options? World J Gastroenterol 2014; 20(28): 9361-9373 [PMID: 25071331 DOI: 10.3748/wjg.v20.i28.9361] [Cited by in F6Publishing: 33] [Reference Citation Analysis]
4 Voutsadakis IA. Molecular predictors of gemcitabine response in pancreatic cancer. World J Gastrointest Oncol 2011; 3(11): 153-164 [PMID: 22110842 DOI: 10.4251/wjgo.v3.i11.153] [Cited by in CrossRef: 52] [Cited by in F6Publishing: 45] [Article Influence: 4.7] [Reference Citation Analysis]